Real-time AI-assisted Endocyroscopy for the Diagnosis of Colorectal Lesions
Real-time AI-assisted Endocytoscopy for the Diagnosis of Colorectal Lesions: a Multi-center, Prospective Clinical Study
1 other identifier
observational
570
1 country
3
Brief Summary
Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death worldwide. Colonoscopy is considered the preferred method of screening for colorectal cancer, and early and resection detection of colorectal neoplastic lesions can significantly reduce colorectal cancer morbidity and mortality. In order to improve the diagnostic accuracy of endoscopy for colorectal lesions, many endoscopic techniques, such as image-enhanced endoscopy, including narrow band imaging (narrow-band imaging, NBI), magnifying endoscopy, pigment endoscopy, confocal laser endoscopy, and endocytoscopy(EC), are applied clinically. However, with the increasing number of endoscopic resection, the costs associated with the pathological diagnosis of endoscopic resection and resection specimens increase year by year. In clinical practice, some non-neoplastic colorectal lesions may not require resection, so it is important to identify the nature of the lesion during colonoscopy. Leveraging deep neural networks, AI systems support both computer-aided detection (CADe) and computer-aided classification (CADx). CADe specifically focuses on identifying polyps in colonoscopy, with the goal of reducing adenoma miss rates. Hovever, CADx can predict the pathology of the lesion based on the surface condition of the lesion. Endocytoscopy is a kind of ultra-high magnification endoscopy. But it is not something that can be easily mastered by endoscopic doctors. The investigators have previously developed an artificial intelligence system that can assist in endocytoscopy. The investigators plan to conduct a prospective, multicenter clinical trial to verify the accuracy of this CADx in predicting the histological characteristics of colorectal lesions during real-time endocytoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2025
CompletedFirst Posted
Study publicly available on registry
January 24, 2025
CompletedStudy Start
First participant enrolled
February 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2025
CompletedApril 13, 2026
April 1, 2026
11 months
January 20, 2025
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the diagnostic performance of the CAD-stained in diagnosing neoplastic lesions in a clinical setting.
The diagnostic performance will be calculated for comparison with final histology as the gold standard for diagnosis
11 months
Secondary Outcomes (4)
To evaluate the diagnostic performance of the CAD-NBI in diagnosing neoplastic lesions in a clinical setting.
11 months
To compare the diagnostic performance of CAD-NBI and CAD-stained in colorectal neoplastic lesions different colorectal lesions.
11 months
To evaluate the diagnostic performance of CAD-NBI and CAD-stained in the diagnosis of neoplastic DRSPs with high confidence
11 months
To evaluate the agreement of post-polypectomy surveillance intervals based on CAD-NBI and CAD-stained predictions with histopathological diagnosis
11 months
Study Arms (1)
Patients with one or more colorectao lesion detected
During colonoscopy, the endoscopist inspect for the presence of colorectal lesions as per routine clinical practice with the CADx turned off. When a colorectal lesion is encountered, the endoscopist will make a prediction on the histology based on the endoscopic diagnosis. Following this, the CADx will be triggered and display the endoscopic image captured by the endoscopist. and the endoscopist will take note of the CADx prediction for the same image. In addition, other lesion features such as the size and location will be recorded, which is similar to what is performed in routine clinical practice. The lesion will be endoscopic resected or surgery and sent for pathological examination, which will form the "gold standard" for the diagnosis of polyp histology.
Interventions
The CADx support tool will display the prediction results when the endoscopists press the keys on the fixed keyboard. This is performed after the endoscopists first makes an optical prediction of colorectal lesion histology using endocytoscopy as described. The CADx support tool will make a prediction of colorectal lesion histology.
Eligibility Criteria
Patients with one or more colorectal lesions detected during endocytoscopy will be included in the study. The rest of the inclusion and exclusion criteria are as described.
You may qualify if:
- Patients who have at least one colorectal lesion detected during endocytoscopy
- Consent obtained for the study
You may not qualify if:
- lesions lacking high-quality images;
- Inflammatory bowel disease, familial adenomatous polyposis and other special diseases;
- Submucosal tumors;
- Pathological diagnosis of inflammatory polyps, Peutz-Jeghers polyps, juvenile polyps, lymphoma and other special pathological types.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The First Hospital of Jilin Universitylead
- Meihekou Central Hospitalcollaborator
- Shandong Second Provincial General Hospitalcollaborator
Study Sites (3)
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
Meihekou Central Hospital
Meihekou, Jilin, 135000, China
Shandong Second Provincial General Hospital
Jinan, Shandong, 250000, China
Biospecimen
Histological specimens obtained after endoscopic or surgical treatment of colorectal lesions
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hong Xu, Docror
The First Hospital of Jilin University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Head of Gastroenterology and Endoscopy Center, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
January 20, 2025
First Posted
January 24, 2025
Study Start
February 5, 2025
Primary Completion
December 29, 2025
Study Completion
December 29, 2025
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share